Conclusion: The Transformative Role of Machine Learning in Genomic Science and Healthcare

Abstract

This final chapter reiterates the revolutionary contribution of machine learning to genomic medicine and healthcare. It points to the growing role played by AI-based methodologies, especially deep learning architectures such as CNNs, in speeding genomic data analysis, increasing diagnostic accuracy, and making personalised medicine possible. Other methods like reinforcement learning and GANs also continue to revolutionise drug discovery and modeling complex biological interactions. Machine learning applies to a wide range of applications across realms such as cancer diagnosis and the study of rare genetic diseases, with companies such as DeepMind and 23andMe at the forefront of innovation. With technologies such as next-gen sequencing and CRISPR converging with AI, the possibilities for accurate, affordable, and personalised healthcare expand exponentially. The author foresees the synergy between genomics and AI transforming medicine into a more predictive and preventive approach, opening the doors to a new era of healthcare solutions across the lifespan.

Ähnliche Arbeiten